Vaccines are derived from a variety of sources including tissue extracts, bacterial cells, virus
particles, recombinant mammalian, yeast and insect cell produced proteins and nucleic …

Vi capsular polysaccharide, a linear homopolymer of α-1, 4-linked N-
acetylgalactosaminuronate, is characteristically produced by Salmonella enterica serovar …

Salmonella enterica serovar Typhi is the causative agent of typhoid fever restricted to
humans and does not replicate in commonly used inbred mice. Genetic variation in humans …

CRM197 is a commonly used glycoconjugate carrier that improves the immunogenicity of
vaccines, particularly in infants. Despite the advantages of this diphtheria toxoid mutant, low …

This report covers the topics of pandemics, epidemics and partnerships, including regulatory
convergence initiatives, new technologies and novel vaccines, discussed by leading public …

This study assessed the effectiveness of the treatment of tomato seeds with an aqueous
extract of the dried biomass of the microalga Anabaena minutissima in protecting the plants …

Circulating IgM present in the body prior to any apparent Ag exposure is referred to as
natural IgM. Natural IgM provides protective immunity against a variety of pathogens …

Activation of B cells and T cells requires the engagement of costimulatory signaling
pathways in addition to Ag receptor signaling for efficient immune responses. None of the …

None of the typhoid Vi Polysaccharide (ViPS) subunit vaccines incorporate adjuvants, and
the immunogenicity of ViPS vaccines (eg Typbar TCV® and Typhim Vi®) is in part due to …

The O specific polysaccharide (OSP) of the lipopolysaccharide (LPS) of Salmonella enterica
serovar Paratyphi A is a protective antigen and the target for vaccine development. LPS is …